⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13451612 | 1.00 | — | — | |
| SCHEMBL13627720 | 1.00 | — | — | |
| SCHEMBL2785652 | 0.80 | MCL1 (0.40) | — | |
| SCHEMBL97236 | 0.80 | — | — | |
| SCHEMBL17617093 | 0.80 | — | — | |
| SCHEMBL24286776 | 0.79 | ATM (0.38) | — | |
| Hydrochloric Acid SCHEMBL11001835 | 0.78 | — | — | |
| SCHEMBL16486600 | 0.78 | — | — | |
| SCHEMBL14242984 | 0.77 | ALDH1A1 (0.32) | — | |
| SCHEMBL9925424 | 0.77 | MCL1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4444691-A1 | EXTRACTION OF POLYHYDROXYALKANOATES FROM BIOMASS, AND USES THEREOF | Hes-so Valais-wallis (CH) | 2024-10-16 | — | — | EP | disclosed |
| US-20240025882-A1 | BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF | LYNK PHARMACEUTICALS CO. LTD. (CN) | 2024-01-25 | — | — | US | disclosed |
| WO-2023104316-A1 | EXTRACTION OF POLYHYDROXYALKANOATES FROM BIOMASS, AND USES THEREOF | HES-SO VALAIS-WALLIS (CH) | 2023-06-15 | — | — | WO | disclosed |
| US-20230143612-A1 | SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME | ARBUTUS BIOPHARMA CORP (US) | 2023-05-11 | — | — | US | disclosed |
| US-20230144528-A1 | CDK Inhibitors And Their Use As Pharmaceuticals | PRELUDE THERAPEUTICS, INCORPORATED | 2023-05-11 | — | — | US | disclosed |
| CN-115551864-A | Substituted tricyclic amides, analogs thereof, and methods of using the same | 爱彼特生物制药公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-109661398-B | Spiro-lactam and di-spiro-lactam NMDA receptor modulators and uses thereof | 阿普廷伊克斯股份有限公司 | 2022-07-05 | — | — | CN | disclosed |
| US-9688603-B2 | Polyhydroxyalkanoate derivatives, preparation and uses thereof | MICROMIDAS, INC. (US) | 2017-06-27 | — | — | US | disclosed |
| US-20170096385-A1 | POLYHYDROXYALKANOATE DERIVATIVES, PREPARATION AND USES THEREOF | MICROMIDAS, INC. (US) | 2017-04-06 | — | — | US | disclosed |
| US-9561259-B2 | Cyclosporin analogs | ALLERGAN, INC. (US) | 2017-02-07 | — | — | US | disclosed |
| US-8952183-B2 | Inhibitors of sialidase or sialidase-like enzymes | NATIONAL RESEARCH COUNCIL OF CANADA | 2015-02-10 | — | — | US | disclosed |
| US-8952183-B2 | Inhibitors of sialidase or sialidase-like enzymes | NATIONAL RESEARCH COUNCIL OF CANADA | 2015-02-10 | — | — | US | disclosed |
| US-20120135939-A1 | Cyclosporin Analogs | ALLERGAN, INC. (US) | 2012-05-31 | — | — | US | disclosed |
| US-7919623-B2 | Naphthyridine derivatives having inhibitory activity against HIV integrase | SHIONOGI & CO., LTD. (JP) | 2011-04-05 | — | — | US | disclosed |
| US-7919623-B2 | Naphthyridine derivatives having inhibitory activity against HIV integrase | SHIONOGI & CO., LTD. (JP) | 2011-04-05 | — | — | US | disclosed |
| US-20090227621-A1 | Naphthyridine derivatives having inhibitory activity against hiv integrase | SHIONOGI & CO., LTD. (JP) | 2009-09-10 | — | — | US | disclosed |
| US-20090227621-A1 | Naphthyridine derivatives having inhibitory activity against hiv integrase | SHIONOGI & CO., LTD. (JP) | 2009-09-10 | — | — | US | disclosed |
| EP-1723102-A2 | N-SUBSTITUTED BENZENE SULFONAMIDES | Elan Pharmaceuticals, Inc. (US) | 2006-11-22 | — | — | EP | disclosed |
| US-20060046286-A1 | Method for preparing optically active beta-butyrolactones | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-03-02 | — | — | US | disclosed |
| WO-2005090296-A2 | N-SUBSTITUTED BENZENE SULFONAMIDES | ELAN PHARMACEUTICALS, INC. (US) | 2005-09-29 | — | — | WO | disclosed |